Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2023 Earnings Call

Jazz Pharmaceuticals plc misses on earnings expectations. Reported EPS is $5.02 EPS, expectations were $5.26.

Related Keywords

United States , Japan , Japanese , America , Ashish Verma , Bruce Cozadd , Andrea Flynn , Marc Goodman , Jessica Fye , David Amsellem , Eli Lilly , Philip Johnson , Jason Gerberry , Annabel Samimy , Joseph Thome , Piper Sandler , Gregory Renza , Rob Iannone , Group Vice , Genentech , Needham Company , Jp Morgan , Jazz Pharmaceuticals , Jazz Pharmaceuticals Fourth Quarter , Amgen , Nasdaq , Jazz Pharmaceuticals Plc , Call Transcript February , Chief Executive Officer , Renee Gala , Chief Operating Officer , Executive Vice President , Global Head , Chief Financial Officer , Group Vice President , Digital Media Stocks To Buy , Buy According , Erwiniai M , Ami Fadia , Thanks Ami ,